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ABSTRACT Objective: Lighting is a strong synchronizer for circadian rhythms, which in turn drives a
wide range of biological functions. The objective of our work is a) to construct a clinical in-patient testbed
with smartİ lighting, and b) evaluate its feasibility for use in future clinical studies. Methods: A feedback
capable, variable spectrum lighting system was installed at the University of New Mexico Hospital. The
system consists of variable spectrum lighting troffers, color sensors, occupancy sensors, and computing and
communication infrastructure. We conducted a pilot study to demonstrate proof of principle, that 1) this
new technology is capable of providing continuous lighting and sensing in an active clinical environment,
2) subject recruitment and retention is feasible for round-the-clock, multi-day studies, and 3) current
techniques for circadian regulation can be deployed in this unique testbed. Unlike light box studies, only
troffer-based lighting was used, and both lighting intensity and spectral content were varied. Results: The
hardware and software functioned seamlessly to gather biometric data and provide the desired lighting.
Salivary samples that measure dim-light melatonin onset showed phase advancement for all three subjects.
Conclusion: We executed a five-day circadian rhythm study that varied intensity, spectrum, and timing of
lighting as proof-of-concept or future clinical studies with troffer-based, variable spectrum lighting. Clinical
Impact: The ability to perform circadian rhythm experiments in more realistic environments that do not overly
constrain the subject is important for translating lighting research into practice, as well as for further research
on the health impacts of lighting.
INDEX TERMS Lighting control, system implementation, circadian rhythm, biomedical engineering.
I. INTRODUCTION
Advances in light emitting diode (LED) technology have
made tunable spectral combinations commercially feasible,
with a growing market for tunable lighting (i.e., Signify (for-
merly Phillips Lighting), Acuity Brands) and lighting control
software (i.e., Nest, F.lux, Philips Hue). ‘‘Smart’’ lighting,
that incorporates feedback from personal sensing devices
(actigraphy, skin temperature, and others) into the control
of variable spectrum LED light fixtures, has the potential
for enormous impact in a variety of environments, including
classrooms, workplaces, health care facilities, andmany other
arenas [1]–[4]. In hospitals, there is emerging evidence that
carefully designed lighting (that varies intensity as well as
spectral power distribution) may improve recovery times and
even health outcomes [4]–[6]. Further, light exposure has
been shown to affect not only circadian phase, but also atten-
tion, cognitive throughput, and alertness [7]–[10].
Lighting is a strong synchronizer for circadian rhythms,
a 24-hour periodic cycle in biological processes that drives
a wide range of biological functions. Circadian disruption
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has been associated with serious health effects, including
gastrointestinal disorders, diabetes, obesity, cardiovascular
disorders, and an increased risk of cancer [11]–[15]. Delayed
sleep-wake phase disorder, which affects more than one mil-
lion Americans (many of whom are teenagers), is associ-
ated with poor school performance and mood disturbances
[1], [16]. Further, a higher likelihood of accidents is preva-
lent for the 20% of American workers with non-standard
hours [13], [17].Many of these and other findings have fueled
concerns about the ubiquity of electrical lighting.
Smart lighting systems also have the potential to improve
health and well being. In hospitals, smart lighting could be
used to re-entrain circadian rhythms in intensive care and
post-operative patients. Variable spectrum lighting has been
installed in health care facilities in Scandinavia [3], [18] and
in the United States [19]; these facilities consist of full spec-
trum, color tunable lighting fixtures. Lighting in workplaces
and in homes could help night-shift workers and others with
non-traditional hours. Worker productivity and energy con-
servation are the focus of research at theWell Living Lab [20],
which uses correlated color temperature (CCT) tunable fix-
tures within a restricted variable CCT range. At Rensselaer
Polytechnic Institute (RPI), a variable spectrum lighting sys-
tem was installed in the Smart Conference Room [21], with
the support of the National Science Foundation (NSF) Engi-
neering Research Center in Lighting Enabled Systems and
Applications (LESA). The Smart Conference Room has been
employed to investigate energy conservation through sens-
ing of external lighting [21], integration of occupancy sens-
ing and activity detection with lighting controls [22], [23],
and lighting to improve cognitive throughput [24], amongst
others.
LESA recently helped facilitate construction of an
in-patient, smart lighting clinical testbed at the University
of New Mexico (UNM) Hospital (Figure 1). The testbed
is located in the Clinical and Translational Science Center
(CTSC), which is part of an NIH-funded consortium for
translation of fundamental science into technology for patient
care. The UNM smart lighting clinical testbed is a unique
facility in theUS: it is an integrated system that consists of full
spectrum LED troffers, time-of-flight sensors for occupancy
detection, and color sensors. In contrast to other deployed
variable spectrum lighting systems, the additional sensing
capabilities enables the potential for real-time, biometric
feedback in lighting control. Further, because the system is
internet-based, the testbed can also be coupled with internet-
based wearable devices. The testbed allows a wide variation
in spectral power density, and the capability of customization
and adaptation to individual subjects. Additionally, the choice
of software architecture and device management facilitates
multi-day experiments under controlled conditions, a dura-
tion necessary for experiments on the time-scale of circadian
processes.
A preliminary version of this work has been reported
in [25], which focused on the testbed hardware and instal-
lation. Here, we describe the results of a small, pilot study
FIGURE 1. The UNM smart lighting clinical testbed (a) prior to installation
and (b) after installation.
conducted in the testbed, demonstrating its feasibility for
use in future clinical studies, and also describe the design
of reliable and robust software and middleware, which was
critical for operation of the testbed over many consecutive
days. The remainder of the paper is as follows: Section II
describes the testbed design (including hardware, middle-
ware, and software) and installation. Section III presents
the experiment design for the pilot study, which focused on
circadian phase advancement. Results of the pilot study are
presented in Section IV and discussed in Section V. Conclu-
sions are presented in Section VI.
FIGURE 2. Physical layout of testbed infrastructure.
II. BACKGROUND AND APPROACH
A. INFRASTRUCTURE ELEMENTS
The UNM Smart Lighting Clinical Testbed is based on a
design previously implemented at RPI in the Smart Con-
ference Room [21]. Most elements of the RPI design are
duplicated, with some significant differences due to con-
straints arising from a clinical environment. The system
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FIGURE 3. (a) Network schematic to control variable spectrum luminaires. (b) Server without (left) and with (right) customized plexiglass
covering.
(Figure 2) consists of 4 Telelumen Penta Luminaires [26],
8 Iris IRMA MATRIX time-of-flight sensors [27], and
48 AMS TCS34725 color sensors [28].
The Telelumen Penta Luminaire fixtures are controllable,
variable spectrum lighting sources consisting of five LED
channels: red, green, blue, and phosphor-converted amber
and white. The intensity of each channel can be varied
individually, allowing for a broad selection of colors and
intensities. Empirically, the luminaires can generate white
light in the range of 1800–10000 K, with a color rendition
index (CRI) greater than 66. Each color-tunable light fixture
is connected, via ethernet, to an ethernet switch, to enable
communication to each source independently.
The color sensors, manufactured by AMS-TAOS, are
small, low-voltage, 4-channel RGBC sensors measuring red,
green, blue, and clear (unfiltered) color intensities. Each sen-
sor communicates via an I2C interface and is powered over
ethernet. The sensors are connected to six, 8-channel mul-
tiplexors, which connect to a Raspberry Pi microcontroller
(Figure 3). Themicrocontroller has custom code for receiving
data from the color sensors, and is connected to the local
network to allow communication with the rest of the testbed
system.
The IRMAMATRIX time-of-flight devices each consist of
an array of 25× 20 single-pixel time-of-flight sensors. Each
pixel time-of-flight sensormeasures the approximate distance
from the ceiling to an object underneath. The pixel time-of-
flight sensors are aligned at different angles of incidence from
the ceiling, to provide a broad field of view. The combined
pixel sensors allow for a privacy preserving measurement of
objects or persons in the room. The time-of-flight sensors are
intentionally coarse to assure privacy, and can be polled as
frequently as 10 Hz.
The IRMA MATRIX devices communicate through a
proprietary messaging protocol that uses the Universal
Datagram Protocol (UDP). Thus, communication with the
time-of-flight sensors must be implemented in C++, via
the manufacturer’s (Iris-Gmbh) Application Programming
Interface (API). Recent development in sensor technology
has enabled small, inexpensive, time-of-flight sensors that
have open communication protocols, such as the Heptagon
OLIVIA [29].
B. SYSTEM DESIGN
Two key design restrictions associated with the clinical envi-
ronment were 1) the need for ongoing use of the room as a
standard hospital room, with standard lighting, when not in
use for research, and 2) the need for manual control of the
sensors and actuators by the study coordinator or the charge
nurse. To address the former need, the variable spectrum
lighting system was installed alongside the existing lighting
system (Figure 1(b)). Existing lighting fixtures and HVAC
elements restricted placement of the sensors and actuators
(Figure 2). Regarding the latter need, a hard switch to shut
off power to the luminaires was installed, covered by a hinged
box to discourage patient use but still allow the charge nurse
to power the luminaires off, if necessary.
As shown in Figure 3(a), sensors and actuators are wired
to an internet connected server. The server is located in an
adjacent clinical laboratory that is operated by the CTSC. The
laboratory maintains a College of American Pathologists cer-
tification, which requires that all surfaces must be regularly
wiped down to prevent particulate contamination. Ethernet
cabling that connects the devices to the remote server was
fed through the ceiling of the testbed (Figure 3(b), left), then
into a custom designed plexiglass covering for the server
(Figure 3(b), right), for easy cleaning.
In an effort to avoid particulate contamination, physical
access to the server room was significantly limited. Hence,
establishing remote access to the server for troubleshooting,
maintenance, and testing was paramount. The remote system
access is protected by two layers of security: one in accessing
the local intranet, and another through password secured user
accounts. A Raritan power distribution unit was installed to
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allow remote disconnection of the power, in the event of
unexpected device behavior, e.g. if the luminaires remained
on even when the wall switch was turned off.
The devices in the testbed communicate via socket
communication, which is supported by most programming
languages, e.g. Python, C++, C#, MATLAB, etc.
C. SOFTWARE DESIGN
Development of reliable middleware is of the utmost impor-
tance for implementation of code that must run continuously
for at least five days, and for which in-person troubleshoot-
ing and testing is quite limited. We developed methodolog-
ical approaches for data management and fault handling
(including diagnostics, alerting, ‘‘soft’’ fails, consistent time-
stamping, and other functionality), as well as a framework for
code sharing (with history, version control, branching, tags,
changes in ownership, etc.).
All of the developed code is stored in an online Git reposi-
tory, to collaboratively share code between the Smart Confer-
ence Room at RPI and the Smart Lighting Clinical Testbed at
UNM. The new repository and code sharing enabled devel-
opments in the Smart Lighting Clinical testbed to be applied
to the Smart Conference Room, and vice versa.
The code for the clinical testbed was developed in Python,
except for the code for the time-of-flight sensors, which was
written in C++, due to device requirements. Python was
selected for several reasons. First, it is open source, which
eliminates licensing requirements and potential errors arising
from license expiration. Second, it is an interpreted language,
as opposed to a compiled language, which allows for fast
prototyping. Because of the very limited testing and debug-
ging time available, this was crucial. Finally, Python is a sta-
ble language with strong socket communication interfacing,
allowing it to successfully run for up to five days.
FIGURE 4. Software design schematic; foundational elements are
consistent across testbeds with testbed-specific configuration files and
an event-driven controller design so that researcher could design for
multiple systems or create custom simulations.
The code is structured in two categories: foundational
elements, which include class structures for controlling how
to communicate with the luminaries and other sensors, and
user-defined elements, which are specific to an experiment
design (Figure 4). This separation was critical for designing
software that was functional across multiple testbed environ-
ments. The foundational elements allowed for a consistent
communication language to be developed such that individual
researchers could easily create the commands necessary for
a given experiment design. Each environment contained a
testbed configuration file, which defined the network location
and type of various elements in the testbed, allowing experi-
ments to be developed that could be implemented in different
testbeds.
To implement the desired lighting profiles for the pilot
study, lighting commands needed to be absolutely timed, e.g.
‘‘turn lights to 1800 K at 18:30 on September 12, 2017.’’
To achieve this, two features were implemented: 1) a queuing
system combining absolute date-time stamps and priority val-
ues (to resolve equal date-time conflicts), and 2) a simulation
controller that would check for available events from the
queue to execute. The simulation controller also checks the
connections to the various testbed elements, e.g. the lumi-
naires, to ensure that there are no connectivity problems.
Another challenge for implementation was the strict need
for continuous execution over a duration of up to five days.
In order to ensure that the testbed operated correctly without
failure for the entire duration of the experiment, extensive
debugging was performed on actions that could cause errors.
Additionally, an error-reporting system was created to handle
both soft and hard errors. The error-reporting system contacts
an on-call administrator in the event of either soft or hard
errors. Soft errors are errors that do not require that the simu-
lation software be reset, such as a failure to communicate with
the color sensors (which would not affect patient experience
during the pilot study). A hard error, such as failure to connect
to the Telelumen luminaires, requires the immediate action of
the administrator to reset the system.
D. SYSTEM INSTALLATION AND VALIDATION
Installation of the variable spectrum lighting system required
approval by and coordination amongst multiple entities,
including NSF LESA, the UNM Center for High Technol-
ogy Materials, the UNM Hospital, the UNM Sleep Disor-
ders Center, and the CTSC. A core group of faculty who
represented the research priorities for the completed testbed
held discussions with these entities individually as well as
jointly. Amemorandum of understandingwith the CTSC, that
outlines responsibilities and anticipated usage of the room
after installation, was completed. Because the UNMHospital
has extremely high usage (it is the only Level 1 trauma center
in NewMexico), and is almost always near capacity, access to
the room was typically determined on extremely short notice
(usually after an occupant was discharged).
Our approach to design of the system was based on that
implemented in the RPI Smart Conference Room. We first
characterized the pre-existing light intensity: data were gath-
ered with a light meter at two heights, 30 and 46 inches,
at locations on a grid with 2 foot spacing in two directions,
excluding the area occupied by the bed. The room was mod-
eled in LitePro 2.0, and the light output of the luminaires
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predicted under several configurations. The selected config-
urations assure that light levels have at least the same value
as compared to standard hospital lighting, and an acceptably
uniform distribution of light at the two working heights. Uni-
formity is typically represented as the ratio of the minimum
illuminance with respect to the maximum illuminance in a
given area [30], and captures the evenness of the spatial
distribution of light; values of 0.7 or higher are typically
considered acceptable by the architectural and lighting design
community. Lastly, the placement of the time-of-flight sen-
sors was guided by the need for complete coverage with
minimal overlap.
UNMHospital Facilities requested bids for the installation
from contractors familiar with the special requirements asso-
ciated with a clinical environment (e.g., particulate contain-
ment and mitigation). Once a bid was selected, an installation
date was scheduled around known patient requirements, with
1.5 days for installation and 0.5 days for troubleshooting.
Due to the room’s frequent use, additional time for trou-
bleshooting was scheduled opportunistically, based on room
availability. Blackout shades were installed for full control of
light in the room. The hardware installation was completed
in November 2015, and all troubleshooting completed by
April 2016.
III. METHODS AND PROCEDURES
Because the testbed is novel, and incorporates state-of-the-art
technology for lighting, sensing, and control, that is atypical
of existing testbeds, the pilot study presents a preliminary
investigation to identify what changes would be necessary
in preparation for future, full-scale clinical studies in the
testbed. The primary goal of the pilot study is to demonstrate
proof of concept, that is, to show that it is possible for the
testbed to a) deliver color-tunable lighting, to sense occu-
pancy, and to sense spectral content of the lighting sources,
in an in-patient testbed over the duration of a multi-day study,
without service interruptions or other technical failures, and
b) to successfully recruit subjects who complete the full study.
A secondary goal of the pilot study was to to determine if
established techniques for circadian regulation and testing of
lighting can be used in this unique testbed. We chose to focus
on circadian regulation, since irregular and interrupted sleep
can be common in hospital settings [31].
A. SUBJECT ELIGIBILITY
The experiment protocol was approved by the UNM Human
Research Review Committee through Study ID 16-178 on
July 21, 2016.
Eligibility criteria for the pilot study included subjects
between the ages of 18–65 with no diagnosed sleep disorders.
Subjects additionally were required to refrain from alcohol
consumption for the duration of the hospital stay, as well as
during the sleep screening for twoweeks prior. Three females,
with ages 33, 62, and 37, participated in the study.
B. EXPERIMENT DESIGN
During the two weeks prior to admission to the hospital
testbed, each subject wore an ActiGraph wActiSleep-BT [32]
actigraphy device, to monitor activity level. The actigraphy
device was worn continuously, except when bathing. Addi-
tionally, each subject maintained a sleep diary to log sleep and
wake times, that was updated each morning. Subjects were
told to refrain from consumption of alcohol during this two-
week monitoring phase, but were otherwise not restricted in
their activities.
On the day of admission to the hospital testbed, each sub-
ject arrivedmidday. Subjects returned the actigraph device for
data collection, and had blue-light filters [33] placed on any
device that they intended to bring with them into the hospital
room, including phones, computers, or tablets. The filter char-
acteristics, as described by the manufacturer, are intended to
block all wavelengths below 530 nm, and most wavelengths
below 550 nm, i.e., those corresponding to blue light. The
subject then returned to the hospital sometime 17:00–18:00,
at which time the subject was admitted by the nursing staff.
The subject was given a new actigraph to wear for the dura-
tion of the in-testbed portion of the study. Device model
ActiGraph wActiSleep-BT was used for subjects 010 and
012, and an ActiGraph GTX3+ [34] was used for subject
006. The subject’s height, weight, and blood pressure were
measured. During the subject’s stay in the testbed, all food
consumption was strictly regulated, no alcohol consump-
tion was allowed, and sleep-altering medications were not
allowed.
In the testbed, the subject was allowed to move freely
around the room and use electronic devices with applied
filters (including the television, and the subject’s phones or
computers). The experimental protocol required that:
• The subject was not allowed to leave the room, and the
door to the hospital room remained closed, except for
when nursing or hospital staff entered or exited the room.
• During dim-light melatonin onset (DLMO) measure-
ments, the subject was not allowed to use any electronic
devices and was instructed to avoid physical activity.
• During periods of darkness (sleep opportunity), the sub-
ject was not allowed to use any electronic devices.
To ensure that the subject did not use electronic devices
during DLMO measurements and sleep periods, the devices
were collected and stored in a locked container, accessible
only to the nursing staff. The devices were returned after the
DLMO measurements or sleep period ended.
Salivary melatonin measurements were collected twice
during the subject’s stay, on days 1 and 4. Samples were
collected every 30 minutes for a period of 6 hours on day
1 and 8 hours on day 4, for a total of 28 samples per subject.
Salivary samples followed the procedure in [35]. Samples
were collected with Salivettes (cat. 51.1534; Sarstedt
Australia Pty. Ltd., Mawson Lakes, South Australia) while
the subjects lay in a supine position in bed, in dim light
3200110 VOLUME 7, 2019
J. D. Gleason et al.: Smart Lighting Clinical Testbed Pilot Study on Circadian Phase Advancement
FIGURE 5. Lighting protocol for the UNMH pilot study for subject 006. Lighting was set to 3 pre-selected color temperatures,
1800 K, 4600 K, 10 000 K, or was turned off. The gray bars represent times that are not part of the study. Lighting illuminances are
shown in Table 1.
(<10 lux, 1800 K). Food and water were consumed only after
saliva collection to reduce contamination or dilution of the
sample. Participants were instructed to place the swab in their
mouth and accumulate saliva for 2 min. After collection, sam-
ples were stored at −20 Celsius. For analysis, samples were
thawed and centrifuged for 10 min at 2500 rpm, the swabs
were removed from the casing, and the supernatant retained.
A sensitive (4.3 pM) direct radioimmunoassay using reagents
from Buhlmann Laboratories AG (Allschwil, Switzerland)
was used to measure melatonin in the saliva.
C. LIGHTING PROTOCOL
We designed a lighting protocol, shown in Figure 5, based on
one used in light-box therapy [37], to phase advance subjects
with troffer-based LED lighting. The protocol consisted of
high color temperature light (10 000 K) in the mornings,
standard illumination (4600 K) during the day, and a 6 hour
period of dim, low light (1800 K) in the evening, before an
8 hour sleep period with no lighting (0 K). For comfort of
the subject, there was a smooth 15 minute transition between
each color temperature setting.
The starting sleep time for the study was determined via
examination of the sleep diary kept for the two weeks prior
to admittance to the testbed. The sleep hour was set one hour
earlier each day to facilitate phase advancement. On the final
day, an 8 hour dim light duration was used instead of the
typical 6 hour duration to allow for more melatonin sam-
pling. After melatonin sampling on the fourth day, the subject
could either remain in the testbed to sleep the rest of the
night or could be discharged immediately.
D. SPECTRAL MEASUREMENT
For each color temperature used in the study, spectral mea-
surements were taken at four locations in the room, as
indicated in Figure 2. At each location, five measurements
were taken using a Sekonic Spectromaster c-7000: one facing
the ceiling and one facing each primary wall of the room.
For all measurements, the Spectromaster was raised 44 inches
from the floor. Figure 6 shows a representative spectral power
density for each color temperature, as well as the mean and
standard deviations of the CRI and 1uv values obtained from
all measurements for each setting. The 1uv values satisfy the
ANSI white specification, i.e. 1uv ≤ 0.0054 [38], [39].
TABLE 1. Representative photometric and photopigment parameters for
the three color temperatures used in the pilot study.
The photometric and photopigment parameters are shown
in Table 1. The photopigment parameters were computed
from spectral power measurements using a freely avail-
able, web-based toolbox [40]. This toolbox was adopted
in a CIE report and distributed internationally [41]. More
recently, this toolbox has been developed into an international
standard [42].
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FIGURE 6. Spectral power of 1800 K, 4600 K, and 10 000 K light settings as measured by Sekonic Spectromaster C-7000 [36].
FIGURE 7. Actigraphy data for all three subjects, during the two weeks prior to the in-patient study (left), and during the in-testbed portion of the
experiment (right).
IV. RESULTS
During the approximately 15 days of operation for the pilot
study, no hard errors occurred in the software. One soft error
occurred while subject 006 was in the testbed; the color
sensors refused a connection from the server due to an error
made during system start-up.
The salivary samples obtained during the in-patient
study were analyzed using the Burgess and Eastman 2005
method [44] for assessing DLMO. The DLMO threshold
times and resulting phase differences are shown in Table 2.
All three subjects experienced a phase advance in DLMO
during the experiment.
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TABLE 2. Dim-light Melatonin Onset threshold times using the Burgess
and Eastman 2005 methods [43]. Negative values of phase difference
indicate phase advancement.




The pilot study successfully demonstrates the ability to con-
duct multi-day experiments in which lighting was varied in
both intensity and spectrum, while simultaneously gathering
other non-invasive data. Despite limited physical access for
troubleshooting, the robustness built into the software helped
assure success of the testbed in delivering the commanded
lighting protocols and logging the sensed measurements.
There were no faults in the physical or software design that
would cause interruption or corruption of the data gathered
during the study.
This testbed enables investigation of challenging research
questions associated with more realistic lighting conditions
and living environments. First, research into the design of
spectral and intensity characteristics to affect human health
is still in nascent stages. Many studies test light emitting
devices that emit single spectrums of monochromatic, nar-
row bandwidth or broad bandwidth (e.g. fluorescent) light
[7], [45], [46], not found in typical indoor lighting environ-
ments. A testbed that can vary both spectrum and intensity
could facilitate research in how the spectral content as well
as the dynamic nature of the spectral content can affect
human health. This could have impact on research on dis-
orders for which light-box therapy has been employed, such
as traumatic brain injury [47], mood disorders [48], [49],
Parkinson’s disease [50], and dementia [51].
Second, the spectral power distribution emitted from the
luminaires is necessarily different than the spectral power
distribution experienced by the subject. In conjunction with
ongoing advances in wearable color sensors, the testbed’s
capacity for active feedback of color and intensity sensing can
help drive lighting systems to precisely deliver the necessary
light.
Third, the rapid advances in wearable devices means
that real-time, non-invasive data can be integrated with this
testbed, to facilitate both information gathering (i.e., non-
photic influences on circadian rhythms) as well as person-
alized lighting control. For example, continuously gathered
actigraphy data has been used to non-invasively estimate a
subject’s circadian phase in an ongoingmanner [52]–[54], but
this estimate could also be used to provide feedback-driven
commands to the lighting system in an ongoing fashion.
B. CIRCADIAN PHASE ADVANCEMENT
The circadian phase advancement observed in study partici-
pants could be the result several factors, including shifting the
timing of sleep, shifting the timing of light exposure, as well
as changing the spectral content and irradiance of the lighting.
Unfortunately, isolating the effect of any of these is not
possible, due to the nature of the pilot study. Further, the pres-
ence of device screens, albeit with blue-light filters, further
confounds the ability to causally identify factors responsible
for the phase shift. The phase advancement indicates that it
is possible to implement a circadian-altering protocol in the
testbed.
C. STUDY LIMITATIONS
A significant limitation of the current study is the small
sample size of the pilot group. Further studies would benefit
from a larger cohort as well as using a more homogenous par-
ticipant pool. Factors to control in future lighting comparison
studieswould include age, health status, includingmedication
use, morningness/eveningness of their sleep cycle, weight,
as well as managing or eliminating caffeine, alcohol and nico-
tine consumption. In addition, a study design using a paral-
lel or crossover control group also experiencing an advanced
timing lighting condition but where exposures remain fixed at
a constant intensity and wavelength mixture as a comparison
to variable spectrum and intensity protocol could potentially
lead to more conclusive results.
Another limitation was the allowance of electronic, light-
emitting devices, such as phones and computers, in the study
area. While these devices can affect a person’s circadian
phase, we opted to allow subject to use devices since for our
population for recruitment, students and others affiliated with
the university, we anticipated that banning devices for the
duration of the experiment would make subject recruitment
and retention extremely difficult, if not impossible.
Additionally, when using tunable, solid state (LED) light-
ing, we face trade-offs in achieving good visual perfor-
mance, promoting beneficial health effects and limiting
energy use [5], [6]. Specifically, in the pilot study reported
here, the 10 000 K stimulus had a CRI of only 66, but the
minimumCRI for good light quality is at least 80 [30]. For the
LED devices used, to achieve a 10 000 K stimulus, CRI could
not be raised to a minimum of 80. The solid state lighting
system being installed on the International Space Station
faced the same problem [55]. As LED lighting technology
improves, achieving high CRI and high color temperature
will likely be attainable. The new Telelumen Octa Lumi-
naires report the ability to generate high CRI lighting up
to 90 000 K [26].
VI. CONCLUSIONS
The testbed facility constructed at the University of New
Mexico Hospital is the only active clinical testbed designed
for circadian research that is equipped with variable spec-
trum and intensity lighting technologies, occupancy sensing,
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and color spectra sensing. A pilot study was conducted
to demonstrate the operation of the testbed and imple-
mentation of established protocols (based on light-box
technology) for circadian regulation. The capabilities asso-
ciated with this testbed could facilitate research and devel-
opment of customized, feedback-based, spectrum-variable
lighting to improve health, safety, and productivity, in con-
trolled lighting environments.
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